Aesthetic Plastic Surgery

, Volume 36, Issue 1, pp 193–201 | Cite as

miRNA Expression Profiles in Keloid Tissue and Corresponding Normal Skin Tissue

  • Ying Liu
  • Daping Yang
  • Zhibo Xiao
  • Miaobo Zhang
Original Article



Because the molecular mechanism behind keloid pathogenesis is still largely unknown, the clinical management of keloids remains problematic. miRNA (microRNA) is a novel class of small regulatory RNA that has emerged as post-transcriptional gene repressors and participants in diverse pathophysiological processes of skin disease. In the present study we aimed to investigate expression profiles of miRNA in keloid tissue and to develop a further understanding of the molecular mechanism involved in the pathogenesis of keloids.


miRNA expression profiles in 12 pairs of keloid tissue and corresponding normal skin tissue were analyzed through a mammalian miRNA microarray containing established whole human mature and precursor miRNA sequences. Real-Time quantitative PCR was performed to confirm the array results. The putative targets of differentially expressed miRNA were functionally annotated by bioinformatics approaches.


miRNA microarray analysis identified 32 differentially expressed miRNAs, and a total of 23 miRNAs exhibited higher expression, while 9 miRNAs demonstrated lower expression in keloid tissue than in normal skin tissue. Functional annotations of differentially expressed miRNA targets revealed that they were enriched in several signaling pathways important for scar wound healing.


This study showed that the expressions of many miRNAs were altered in keloid tissue, and their expression profiling may provide a useful clue for exploring the pathogenesis of keloids. miRNAs might partly contribute to the etiology of keloids by affecting several signaling pathways relevant to scar wound healing.


miRNA Keloid tissue Normal skin tissue 



This work was supported by China Postdoctoral Science Foundation (No. 20100471024) and Doctor Foundation of The Second Affiliated Hospital of Harbin Medical University (No. BS2010-21).


The authors declare that they have no conflicts of interest to disclose.


  1. 1.
    Robles DT, Berg D (2007) Abnormal wound healing: keloids. Clin Dermatol 25:26–32PubMedCrossRefGoogle Scholar
  2. 2.
    Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV (2001) Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 107:87–96PubMedCrossRefGoogle Scholar
  3. 3.
    Soifer HS, Rossi JJ, Saetrom P (2007) MicroRNAs in disease and potential therapeutic applications. Mol Ther 15:2070–2079PubMedCrossRefGoogle Scholar
  4. 4.
    Kuehbacher A, Urbich C, Dimmeler S (2008) Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 29:12–15PubMedCrossRefGoogle Scholar
  5. 5.
    Gu W, An J, Ye P, Zhao KN, Antonsson A (2011) Prediction of conserved microRNAs from skin and mucosal human papillomaviruses. Arch Virol. doi: 10.1007/s00705-011-0974-3
  6. 6.
    Xu N, Brodin P, Wei T, Meisgen F, Eidsmo L, Nagy N, Kemeny L, Ståhle M, Sonkoly E, Pivarcsi A (2011) MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol 131(7):1521–1529PubMedCrossRefGoogle Scholar
  7. 7.
    Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120:1298–1309PubMedCrossRefGoogle Scholar
  8. 8.
    Zhang L, Stokes N, Polak L, Fuchs E (2011) Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment. Cell Stem Cell 8:294–308PubMedCrossRefGoogle Scholar
  9. 9.
    Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931–1934PubMedCrossRefGoogle Scholar
  10. 10.
    Lu F, Gao J, Ogawa R, Hyakusoku H (2007) Variations in gap junctional intercellular communication and connexin expression in fibroblasts derived from keloid and hypertrophic scars. Plast Reconstr Surg 119:844–851PubMedCrossRefGoogle Scholar
  11. 11.
    Shih B, Garside E, McGrouther DA, Bayat A (2010) Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen 18:139–153PubMedCrossRefGoogle Scholar
  12. 12.
    Holst LM, Kaczkowski B, Gniadecki R (2010) Reproducible pattern of microRNA in normal human skin. Exp Dermatol 19:201–205CrossRefGoogle Scholar
  13. 13.
    Yi R, Fuchs E (2010) MicroRNA-mediated control in the skin. Cell Death Differ 17:229–235PubMedCrossRefGoogle Scholar
  14. 14.
    Bak RO, Mikkelsen JG (2010) Regulation of cytokines by small RNAs during skin inflammation. J Biomed Sci 1:17–53Google Scholar
  15. 15.
    Caramuta S, Egyházi S, Rodolfo M, Witten D, Hansson J, Larsson C, Lui WO (2010) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 130:2062–2070PubMedCrossRefGoogle Scholar
  16. 16.
    Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, Tsunoda T, Hosono N, Kubo M, Nakamura Y, Zembutsu H (2010) A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 42:768–771PubMedCrossRefGoogle Scholar
  17. 17.
    Russell SB, Russell JD, Trupin KM, Gayden AE, Opalenik SR, Nanney LB, Broquist AH, Raju L, Williams SM (2010) Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 130:2489–2496PubMedCrossRefGoogle Scholar
  18. 18.
    Brown JJ, Bayat A (2009) Genetic susceptibility to raised dermal scarring. Br J Dermatol 161:8–18PubMedCrossRefGoogle Scholar
  19. 19.
    Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB (2008) Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 128:1298–1310PubMedCrossRefGoogle Scholar
  20. 20.
    Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M et al (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 11:e610CrossRefGoogle Scholar
  21. 21.
    Sonkoly E, Wei T (2010) Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. J Invest Dermatol 130:124–134PubMedCrossRefGoogle Scholar
  22. 22.
    McKenna DJ, McDade SS, Patel D, McCance DJ (2010) MiR-203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol 84:10644–10652PubMedCrossRefGoogle Scholar
  23. 23.
    Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA et al (2008) miR-203 represses ‘stemness’ by repressing DNp63. Cell Death Differ 15:1187–1195PubMedCrossRefGoogle Scholar
  24. 24.
    Melar-New M, Laimins LA (2010) Human papillomaviruses modulate expression of miR-203 upon epithelial differentiation to control levels of p63 proteins. J Virol 84:5212–5221PubMedCrossRefGoogle Scholar
  25. 25.
    Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132:4653–4662PubMedCrossRefGoogle Scholar
  26. 26.
    Cioffi JA, Yue WY, Mendolia-Loffredo S, Hansen KR, Wackym PA, Hansen MR (2010) MiR-21 overexpression contributes to vestibular schwannoma cell proliferation and survival. Otol Neurotol 31:1455–1462PubMedGoogle Scholar
  27. 27.
    Friedland DR, Eernisse R, Erbe C, Gupta N, Cioffi JA (2009) Cholesteatoma growth and proliferation: posttranscriptional regulation by miR-21. Otol Neurotol 30:998–1005PubMedCrossRefGoogle Scholar
  28. 28.
    Garofalo M, Di Leva G, Romano G (2009) MiR-221/222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16:498–509PubMedCrossRefGoogle Scholar
  29. 29.
    Yang H, Kong W, He L, Zhao J (2010) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68:425–433CrossRefGoogle Scholar
  30. 30.
    Haitao B, Rang X, Zhong C, Dao W (2011) Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line. FEBS Lett 585:402–408CrossRefGoogle Scholar
  31. 31.
    van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH, Willemze R, Tensen CP, Vermeer MH (2011) MiR-21 expression in CD4 + T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. J Invest Dermatol 131:762–768PubMedCrossRefGoogle Scholar
  32. 32.
    Ryan DG, Oliveira-Fernandes M, Lavker R (2006) MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vision 12:1175–1184Google Scholar
  33. 33.
    Yu J, Ryan DG, Getsios S, Oliveira-Fernandes M, Fatima A, Lavker RM (2008) MiR-184 antagonizes miR-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci USA 105:19300–19305PubMedCrossRefGoogle Scholar
  34. 34.
    Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Ménard S, Croce CM, Tagliabue E (2009) MiR-205 regulates HER3 in human breast cancer. Cancer Res 69:2195–2200PubMedCrossRefGoogle Scholar
  35. 35.
    Yi R, Carroll D, Pasolli HA, Zhang Z, Dietrich FS, Tarakhovsky A, Fuchs E (2006) Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet 38:356–362PubMedCrossRefGoogle Scholar
  36. 36.
    Lee JW, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS (2011) The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol 120:56–62PubMedCrossRefGoogle Scholar
  37. 37.
    Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9:582–589PubMedCrossRefGoogle Scholar
  38. 38.
    Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68:7846–7854PubMedCrossRefGoogle Scholar
  39. 39.
    Hildebrand J, Rütze M, Walz N, Gallinat S, Wenck H, Deppert W, Grundhoff A, Knott A (2011) A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol 131:20–29PubMedCrossRefGoogle Scholar
  40. 40.
    Wei T, Orfanidis K, Xu N, Janson P, Ståhle M, Pivarcsi A, Sonkoly E (2010) The expression of microRNA-203 during human skin morphogenesis. Exp Dermatol 19:854–856PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2011

Authors and Affiliations

  • Ying Liu
    • 1
  • Daping Yang
    • 1
  • Zhibo Xiao
    • 1
  • Miaobo Zhang
    • 1
  1. 1.Department of Plastic SurgeryThe Second Affiliated Hospital of Harbin Medical UniversityHarbin CityPeople’s Republic of China

Personalised recommendations